Effects of One-Stage Full-Mouth Scaling and Root Planing with Azithromycin on Diabetes and Periodontal Disease: A Randomized Controlled Trial
Open Access
- 18 September 2022
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 11 (9) , 1266
Abstract
Recent reports show that hemoglobin A1c (HbA1c) can be lowered by improving chronic inflammation in periodontal patients with diabetes mellitus and that full-mouth scaling and root planing (FM-SRP), in combination with azithromycin (AZM) treatment, can reduce early periodontal inflammation. However, the association of FM-SRP and AZM with periodontitis and HbA1c in patients with diabetes is largely unknown. This study investigated periodontitis and HbA1c in patients with diabetes after receiving FM-SRP and AZM to evaluate which clinical parameters most reflect the diabetic condition. Fifty-one periodontal patients with diabetes mellitus were included in this study. In total, 25 patients were assigned to the FM-SRP group in which patients were treated with FM-SRP in combination with AZM, and 26 patients were assigned to the control group in which only supragingival calculus removal was performed along with the provision of oral hygiene instructions. We evaluated periodontal parameters (probing pocket depth, periodontal inflamed surface area (PISA), bleeding on probing), and periodontal bacteria and biochemical parameters (HbA1c, high-sensitive C-reactive protein (hs-CRP), tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1)) at baseline (BL) and 1, 3, 6, and 9 months after treatment. Compared with BL values, the FM-SRP group showed improved clinical parameters, reduced periodontal pathogens, and significantly lower HbA1c. Inflammatory cytokines (hs-CRP, TNF-α, IL-6) were significantly reduced one month after treatment and remained low thereafter. MCP-1 did not change significantly during the experimental period. PISA showed a strong correlation with HbA1c, hs-CRP, and TNF-α. FM-SRP, in combination with AZM, produced clinical, microbiological, and HbA1c improvements in periodontal patients with previously diagnosed diabetes mellitus. Additionally, PISA was shown to be a useful index for assessing the diabetic status of patients with periodontal disease.Keywords
Funding Information
- Japan Society for the Promotion of Science London (18K09589)
This publication has 43 references indexed in Scilit:
- Periodontal Status and A1C ChangeDiabetes Care, 2010
- Periodontal inflamed surface area: quantifying inflammatory burdenJournal of Clinical Periodontology, 2008
- Effects of Periodontal Therapy on Glycemic Control and Inflammatory MarkersJournal of Periodontology, 2008
- Effect of non‐surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitisJournal of Clinical Periodontology, 2007
- Diabetes Mellitus and Periodontal DiseasesJournal of Periodontology, 2006
- Adiposity Elevates Plasma MCP-1 Levels Leading to the Increased CD11b-positive Monocytes in MiceJournal of Biological Chemistry, 2003
- The Effect of Antimicrobial Periodontal Treatment on Circulating Tumor Necrosis Factor‐Alpha and Glycated Hemoglobin Level in Patients With Type 2 DiabetesJournal of Periodontology, 2001
- Some suspected periodontopathogens and serum antibody response in adult long-duration insulin-dependent diabeticsJournal of Clinical Periodontology, 1995
- Phagocyte uptake and transport of azithromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- The Periodontal Microflora of Juvenile Diabetics: Culture, Immunofluorescence, and Serum Antibody StudiesJournal of Periodontology, 1983